Treatment of drug-resistant pneumococcal meningitis

Current Infectious Disease Reports

Volumn 12, Issue 4, 2010, Pages 274-281

  Hameed, Nida ^a   Tunkel, Allan R ^a  

^a MONMOUTH MEDICAL CENTER   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Antimicrobial therapy; Bacterial meningitis; Blood brain barrier; Carbapenems; Cerebrospinal fluid; Daptomycin; Dexamethasone; Fluoroquinolones; Glycopeptides; Linezolid; Pharmacodynamics; Rifampin; Streptococcus pneumoniae; Third generation cephalosporins

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CLINAFLOXACIN; DAPTOMYCIN; DEXAMETHASONE; ERTAPENEM; GARENOXACIN; GATIFLOXACIN; GEMIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; ORITAVANCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TROVAFLOXACIN; UNINDEXED DRUG; VANCOMYCIN;

ADD ON THERAPY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL MENINGITIS; BACTERIAL STRAIN; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; LIVER TOXICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMOCOCCAL MENINGITIS; REVIEW; SINGLE DRUG DOSE; STREPTOCOCCUS PNEUMONIAE;

EID: 77956264739     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0110-7     Document Type: Review

References (53)

1. AR Tunkel BJ Hartman SL Kaplan, et al. 2004 Practice guidelines for the management of bacterial meningitis Clin Infect Dis 39 1267 1284 10.1086/425368 15494903
2. Centers for Disease Control and Prevention 2008 Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae-United States, 2006-2007 MMWR 57 1353 1355
3. HE Hsu KA Shutt MR Moore, et al. 2009 Effect of pneumococcal conjugate vaccine on pneumococcal meningitis N Engl J Med 360 244 256 10.1056/ NEJMoa0800836 1:CAS:528:DC%2BD1MXnsFCrsw%3D%3D 19144940
4. PC Appelbaum 2002 Resistance among Streptococcus pneumoniae: implications for drug selection Clin Infect Dis 34 1613 1620 10.1086/340400 12032897
5. CN Meyer JS Samuelsson M Galle, et al. 2004 Acute bacterial meningitis: aetiology, penicillin susceptibility, risk factors, prognostic factors and guidelines for empiric antibiotic therapy Clin Microbiol Infect 10 709 717 10.1111/j.1469-0961.2004.00925.x 1:STN:280:DC%2BD2czpvVWkuw%3D%3D 15301673
6. I Lustar GH McCracken Jr 1998 Antibiotic pharmacodynamics in cerebrospinal fluid Clin Infect Dis 27 1117 1129 10.1086/515003
7. DR Andes WA Craig 1999 Pharmacokinetics and pharmacodynamics of antibiotics in meningitis Infect Dis Clin North Am 13 595 618 10.1016/S0891-5520(05)70096-9 1:STN:280:DyaK1MzpvFGkug%3D%3D 10470557
8. SW Sinner AR Tunkel 2004 Antimicrobial agents in the treatment of bacterial meningitis Infect Dis Clin North Am 18 581 602 10.1016/j.idc.2004.04. 005 15308277
9. J Miranda AR Tunkel 2009 Strategies and new developments in the management of bacterial meningitis Infect Dis Clin North Am 23 925 943 10.1016/j.idc.2009.06.014 19909891
10. I Lustar A Ahmed IR Friedland, et al. 1997 Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 41 2414 2417
11. PF Viladrich C Cabellos R Pallares, et al. 1996 High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad spectrum cephalosporins Antimicrob Agents Chemother 40 218 220 1:CAS:528:DyaK28XhvFOgsg%3D%3D 8787909
12. CM Gerber M Cottagnoud K Neftel, et al. 2000 Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro J Antimicrob Chemother 45 63 68 10.1093/jac/45.1.63 1:CAS:528:DC%2BD3cXhtVahurY%3D 10629014
13. P Cottagnoud F Acosta M Cottagnoud, et al. 2002 Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis J Antimicrob Chemother 49 327 330 10.1093/jac/49.2.327 1:CAS:528:DC%2BD38XhsFCgsrk%3D 11815575
14. TP Lodise Jr R Nau M Kinzig, et al. 2007 Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae Diagn Microbiol Infect Dis 58 445 452 10.1016/j.diagmicrobio.2007.03.015 1:CAS:528:DC%2BD2sXovFOqt7o%3D 17512154
15. X Saez-Llorens M O'Ryan 2001 Cefepime in the empiric treatment of meningitis in children Pediatr Infect Dis J 20 356 361 10.1097/00006454- 200103000-00035 1:STN:280:DC%2BD38%2Fgsleisg%3D%3D 11303850
16. A Ahmed 1997 A critical evaluation of vancomycin for treatment of bacterial meningitis Pediatr Infect Dis J 16 895 903 10.1097/00006454-199709000- 00014 1:STN:280:DyaK2svltFGgsQ%3D%3D 9306486
17. IR Friedland M Paris S Ehrett, et al. 1999 Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 43 2372 2375
18. P Cottagnoud M Cottagnoud MG Täuber 2003 Vancomycin acts synergistically with gentamicin against penicillin-resistant pneumococci by increasing the intracellular penetration of gentamicin Antimicrob Agents Chemother 47 144 147 10.1128/AAC.47.1.144-147.2003 1:CAS:528: DC%2BD3sXis12huw%3D%3D 12499182
19. PF Viladrich F Gudiol J Linares, et al. 1991 Evaluation of vancomycin for therapy of adult pneumococcal meningitis Antimicrob Agents Chemother 35 2467 2472 1:STN:280:DyaK383jvVKltA%3D%3D 1810180
20. KP Klugman IR Friedland JS Bradley 1995 Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis Antimicrob Agents Chemother 39 1988 1992 1:CAS:528:DyaK2MXnvVygsbo%3D 8540704
21. JD Ricard M Wolff JC Lacherade, et al. 2007 Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study Clin Infect Dis 44 250 255 10.1086/510390 1:CAS:528:DC%2BD2sXhsVKrsL8%3D 17173226
22. A Ahmed H Jafri I Lustar, et al. 1999 Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 43 876 881 1:CAS:528:DyaK1MXisVSgu7c%3D 10103194
23. R Novak B Henriques E Charpentier, et al. 1999 Emergence of vancomycin tolerance in Streptococcus pneumoniae Nature 399 590 593 10.1038/21202 1:CAS:528:DyaK1MXjvFegtLY%3D 10376600
24. JA McCullers BK English 2000 Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis J Infect Dis 181 369 373 10.1086/315216 1:STN:280:DC%2BD3c%2FoslSgug%3D%3D 10608791
25. CA Rodriguez R Atkinson W Bitar, et al. 2004 Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact J Infect Dis 190 1481 1487 10.1086/424467 1:CAS:528:DC%2BD2cXps1amtLo%3D 15378442
26. M Rybak B Lomaestro JC Rotschafer, et al. 2009 Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am J Health-Syst Pharm 66 82 98 10.2146/ajhp080434 1:CAS:528:DC%2BD1MXhs1Gmtrs%3D 19106348
27. AF Cabellos F Tubau JM Maiques, et al. 2005 Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis J Antimicrob Chemother 55 78 83 15546968
28. J Gerber A Smirnov A Wellmer, et al. 2001 Activity of LY333328 in experimental meningitis caused by a Streptococcus pneumoniae strain susceptible to penicillin Antimicrob Agents Chemother 45 2169 2172 10.1128/AAC.45.7.2169- 2172.2001 1:CAS:528:DC%2BD3MXks1GksbY%3D 11408247
29. C Cabellos A Fernandez JM Maiques 2003 Experimental study of LY333329 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 47 1907 1911 10.1128/AAC.47.6.1907-1911.2003 1:CAS:528:DC%2BD3sXktlymtb4%3D 12760866
30. A Stucki P Gerber F Acosta, et al. 2006 Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters Antimicrob Agents Chemother 50 770 773 10.1128/AAC.50.2.770-773.2006 1:CAS:528: DC%2BD28Xhs1Cntbo%3D 16436742
31. MM Paris SM Hickey MI Uscher, et al. 1994 Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis Antimicrob Agents Chemother 38 1320 1324 1:CAS:528:DyaK2cXktVWgt70%3D 8092832
32. J Martinez-Lacasa C Cabellos A Martos, et al. 2002 Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis J Antimicrob Chemother 49 507 513 10.1093/jac/49.3.507 1:CAS:528:DC%2BD38Xit1Ckt7g%3D 11864951
33. BM Suntur T Yurtseven OR Sipahi, et al. 2005 Rifampicin + ceftriaxone versus vancomycin + ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model Int J Antimicrob Agents 26 258 260 10.1016/j.ijantimicag.2005.06.010 1:CAS:528:DC%2BD2MXpslyht7k%3D 16099624
34. H Lee JH Song SW Kim, et al. 2004 Evaluation of a triple drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis Int J Antimicrob Agents 23 307 310 1:CAS:528:DC%2BD2cXhs12gs78%3D 15164975
35. VK Wong HT Wright Jr LA Ross, et al. 1991 Imipenem/cilastatin treatment of bacterial meningitis in children Pediatr Infect Dis J 10 122 125 10.1097/00006454-199102000-00009 1:STN:280:DyaK3M3ovVWhtQ%3D%3D 2062603
36. P Cottagnoud M Pfister M Cottagnoud, et al. 2003 Activities of ertapenem, a new long acting carbapenem, against penicilliln-sensitive or -resistant pneumococci in experimental meningitis Antimicrob Agents Chemother 47 1943 1947 10.1128/AAC.47.6.1943-1947.2003 1:CAS:528:DC%2BD3sXktlymtbs%3D 12760871
37. E Force F Taberner C Cabellos, et al. 2008 Experimental study of meropenem in the therapy of cephalosporin-susceptible and -resistant pneumococcal meningitis Eur J Clin Microbiol Infect Dis 27 685 690 10.1007/s10096-008-0492-8 1:CAS:528:DC%2BD1cXptVyiu78%3D 18386085
38. E Schmutzhard KJ Williams G Vukmirovits, et al. 1995 A randomized comparison of meropenem with cefotaxime and ceftriaxone for the treatment of bacterial meningitis in adults: meropenem meningitis study group J Antimicrob Chemother 36 Suppl A 85 97 1:CAS:528:DyaK2MXnvFanu7g%3D 8543502
39. KP Klugman R Dagan 1995 Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis Antimicrob Agents Chemother 39 1140 1146 1:CAS:528:DyaK2MXlsVSlsL0%3D 7625802
40. CM Odio JR Puig JM Feris, et al. 1999 Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children Pediatr Infect Dis J 18 581 590 10.1097/00006454-199907000-00004 1:STN:280:DyaK1MzmslSntg%3D%3D 10440432
41. CC John G Aouad B Berman, et al. 1997 Successful meropenem treatment of multiply resistant pneumococcal meningitis Pediatr Infect Dis J 16 1009 1011 10.1097/00006454-199710000-00026 1:STN:280:DyaK1c%2FisF2gtQ%3D%3D 9380459
42. SC Buckingham Y Davis BK English 2002 Pneumococcal susceptibility to meropenem in a mid-south children's hospital South Med J 95 1293 1296 12539996
43. H Schmidt A Dalhoff K Steurtz, et al. 1998 Moxifloxacin in the therapy of experimental pneumococcal meningitis Antimicrob Agents Chemother 42 1397 1401 1:STN:280:DyaK1c3oslGkuw%3D%3D 9624483
44. C Ostergaard TK Sorensen JD Knudsen, et al. 1998 Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits Antimicrob Agents Chemother 42 1706 1712 1:CAS:528:DyaK1cXktlKgsr4%3D 9661008
45. K Kanellakopoulou A Pagoulatou K Stroumpoulis, et al. 2008 Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid in humans: implication for a bactericidal effect J Antimicrob Chemother 61 1328 1331 10.1093/jac/dkn110 1:CAS:528:DC%2BD1cXmtVajtL8%3D 18353805
46. P Cottagnoud M Cottagnoud F Acosta, et al. 2003 Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis Eur J Clin Microbiol Infect Dis 22 656 662 10.1007/s10096-003-1016-1 1:CAS:528: DC%2BD3sXptVCitLw%3D 14557920
47. F Kuhn M Cottagnoud F Acosta, et al. 2003 Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro Antimicrob Agents Chemother 47 2487 2491 10.1128/AAC.47.8.2487-2491.2003 1:STN:280:DC%2BD3szksFyqsw%3D%3D 12878509
48. L Flatz M Cottagnoud F Kuhn, et al. 2004 Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci J Antimicrob Chemother 53 305 310 10.1093/jac/dkh082 1:CAS:528:DC%2BD2cXos1egsg%3D%3D 14729741
49. X Saez-Llorens C McCoig JM Feris, et al. 2002 Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin Pediatr Infect Dis J 21 14 22 10.1097/00006454-200201000-00004 11791092
50. P Cottagnoud M Pfister F Acosta, et al. 2004 Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis Antimicrob Agents Chemother 48 3928 3933 10.1128/AAC.48.10.3928-3933.2004 1:CAS:528:DC%2BD2cXosVygsbk%3D 15388454
51. 3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall Antimicrob Agents Chemother 51 2249 2252 10.1128/AAC.01000-06 1:CAS:528:DC%2BD2sXmtlKrt7o%3D 17371817
52. D Grandgirard C Schurch P Cottagnoud, et al. 2007 Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis Antimicrob Agents Chemother 51 2173 2178 10.1128/AAC.01014-06 1:CAS:528:DC%2BD2sXmtlKrsbo%3D 17371820
53. P Cottagnoud CM Gerber F Acosta, et al. 2000 Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model J Antimicrob Chemother 46 981 985 10.1093/jac/46.6.981 1:CAS:528:DC%2BD3MXotlKg 11102418